Skip to main content

Vistin Pharma ASA: Second quarter and first half 2020 financial results

Oslo, Norway, 28 August 2020Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter and first half of 2020, with a 20% increase in revenue and EBITDA of MNOK 20.9 for the pharmaceutical business in Q2 – highest revenue and EBITDA ever in a quarter. For first half 2020 revenue increased by 30% and EBITDA by 200% versus first half 2019.The revenues for the second quarter of 2020 ended at MNOK 73 (Q2’19: MNOK 61.1). For first half of 2020 the revenue was MNOK 134.4, compared to MNOK 103.3 in first half of 2019, a growth of 30%.Second quarter EBITDA for pharmaceuticals was MNOK 20.9 (Q1’19: MNOK13.3), and a first half 2020 EBITDA of MNOK 35.1, compared to MNOK 11.7 in first half of 2019.The net profit for the group ended at MNOK 20.7 (Q2’19: MNOK 0.4) for the second quarter of 2020. For first half 2020 the net loss was MNOK 110.1, compared to profit of MNOK 2.4 in first half of 2019, driven by the loss of closing the oil derivative portfolio in March.Vistin Pharma had cash of MNOK 109 (Q2’19 MNOK: 290.7) as of 30 June 2020, and a strong balance sheet with an equity ratio of 83%. Dividend of NOK 1 per share was paid to shareholders in June.The second quarter conference call, which will be held today, 28 August, at 8.30am (CEST) and will be available via web and audio through the following access points:Telephone conference:
Confirmation Code:…….. 9358318
International Dial-In:…….. +44 (0) 2071 928338
Norway, Oslo:……………. +47 21563015
United States, New York: +1 6467413167
Webcast:
https://edge.media-server.com/mmc/p/b48bigg6
The conference call will be held in Norwegian.
       
Please find the Q2 and first half 2020 report and presentation enclosed. The report will also be made available on www.vistin.com.*****For further information, please contact:Kjell-Erik Nordby
CEO
+47 91 36 42 80
kjell-erik.nordby@vistin.com
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.AttachmentsVistin Pharma ASA second quarter report 2020Vistin Pharma ASA second quarter presentation 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.